Gene therapy progress and prospects: gene therapy of lysosomal storage disorders
- 1 August 2003
- journal article
- review article
- Published by Springer Nature in Gene Therapy
- Vol. 10 (16) , 1275-1281
- https://doi.org/10.1038/sj.gt.3302092
Abstract
Despite disappointments with early clinical studies, there is continued interest in the development of gene therapy for the group of metabolic diseases referred to as lysosomal storage disorders (LSDs). The LSDs are monogenic and several small and large, representative animal models of the human diseases are available. Further, the successful reconstitution of only low and unregulated tissue levels of the affected lysosomal enzymes are expected to be sufficient to correct the disease at least in the case of some of the LSDs. For these reasons, they are perceived as good models for the evaluation of different gene delivery vectors and of different strategies for treating chronic genetic diseases by gene transfer. In this review, we will highlight the progress that has been made over the past 2 years in preclinical research for this group of disorders and speculate on future prospects.Keywords
This publication has 43 references indexed in Scilit:
- Highly efficient gene transfer into baboon marrow repopulating cells using GALV-pseudotype oncoretroviral vectors produced by human packaging cellsBlood, 2002
- Advances in the treatment of lysosomal storage diseaseDevelopmental Medicine and Child Neurology, 2001
- Gene therapy for lysosomal storage disordersExpert Opinion on Biological Therapy, 2001
- Safety and Efficacy of Recombinant Human α-Galactosidase A Replacement Therapy in Fabry's DiseaseNew England Journal of Medicine, 2001
- Enzyme Replacement Therapy in Fabry DiseaseJAMA, 2001
- Preselective gene therapy for Fabry diseaseProceedings of the National Academy of Sciences, 2001
- Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann–Pick diseaseGene Therapy, 2000
- Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapyThe Journal of Gene Medicine, 2000
- Gene Therapy Using Hematopoietic Stem Cells: Sisyphus Approaches the CrestHuman Gene Therapy, 2000
- Retrovirally expressed human arylsulfatase A corrects the metabolic defect of arylsulfatase A-deficient mouse cellsGene Therapy, 2000